| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47740-0.1mg | |||
| IHC-Prediluted | NBP2-48202 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-54310-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44980 | |||
| Azide and BSA Free | NBP2-34563-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21583-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08966 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-86808-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-32626-25ul | |||
![Western Blot: ID3 Antibody (2B11) [NB500-112] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with Id3 antibody [2B11] diluted at 1:1000. The HRP-conjugated anti-mouse IgG antibody (NBP2-19382) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/ID3-Antibody-2B11-Western-Blot-NB500-112-img0003.jpg "Western Blot: ID3 Antibody (2B11) [NB500-112] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with Id3 antibody [2B11] diluted at 1:1000. The HRP-conjugated anti-mouse IgG antibody (NBP2-19382) was used to detect the primary antibody.")
![Immunocytochemistry/Immunofluorescence: ID3 Antibody (2B11) [NB500-112] - HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: Id3 protein stained by Id3 antibody [2B11] diluted at 1:100. Blue: Hoechst 33342 staining.Scale bar = 10 um.](http://images.novusbio.com/fullsize/ID3-Antibody-2B11-Immunocytochemistry-Immunofluorescence-NB500-112-img0001.jpg)
![Western Blot: Cyclin E1 Antibody [NBP2-16055] - Sample (30 ug of whole cell lysate) A: U87-MG 10% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/Cyclin-E1-Antibody-Western-Blot-NBP2-16055-img0001.jpg "Western Blot: Cyclin E1 Antibody [NBP2-16055] - Sample (30 ug of whole cell lysate) A: U87-MG 10% SDS PAGE gel, diluted at 1:1000.")
![Immunocytochemistry/Immunofluorescence: Cyclin E1 Antibody [NBP2-16055] - Confocal immunofluorescence analysis of paraformaldehyde-fixed HeLa, using Cyclin E1 antibody (Green) at 1:500 dilution. Alpha-tubulin filaments are labeled with Alpha-tubulin antibody (Red) at 1:2000.](http://images.novusbio.com/fullsize/Cyclin-E1-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-16055-img0002.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: Cyclin E1 Antibody [NBP2-16055] - Untreated (-) and treated (+) HCT-116 whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Cyclin E1 antibody. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/Cyclin-E1-Antibody-Western-Blot-NBP2-16055-img0003.jpg)
![Western Blot: Cyclin E1 Antibody [NBP2-16055] - Various whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Cyclin E1 antibody diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.](http://images.novusbio.com/fullsize/Cyclin-E1-Antibody-Western-Blot-NBP2-16055-img0005.jpg)
![Immunohistochemistry-Paraffin: EGFR Antibody (31G7) [NBP2-45148] - Human Placenta stained with EGFR Monoclonal Antibody (31G7).](http://images.novusbio.com/fullsize/EGFR-Antibody-31G7-Immunohistochemistry-Paraffin-NBP2-45148-img0001.jpg "Immunohistochemistry-Paraffin: EGFR Antibody (31G7) [NBP2-45148] - Human Placenta stained with EGFR Monoclonal Antibody (31G7).")
![Protein Array: EGFR Antibody (31G7) [NBP2-45148] - Analysis of Protein Array containing more than 19,000 full-length human proteins using EGFR Antibody (31G7) Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (Monoclonal Antibody) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProt(TM) array. Z-scores are described in units of standard deviations (SD's) above the mean value of all signals generated on that array. If targets on HuProt(TM) are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD's) between the Z-score. S-score therefore represents the relative target specificity of a Monoclonal Antibody to its intended target. A Monoclonal Antibody is considered to specific to its intended target, if the Monoclonal Antibody has an S-score of at least 2.5.](http://images.novusbio.com/fullsize/EGFR-Antibody-31G7-Protein-Array-NBP2-45148-img0003.jpg)
![Western Blot: EGFR Antibody (GFR/1667) [NBP2-53346] - Western Blot Analysis of A431 cell lysate using EGFR antibody (GFR/1667).](http://images.novusbio.com/fullsize/EGFR-Antibody-GFR-1667-Western-Blot-NBP2-53346-img0006.jpg "Western Blot: EGFR Antibody (GFR/1667) [NBP2-53346] - Western Blot Analysis of A431 cell lysate using EGFR antibody (GFR/1667).")
![Immunohistochemistry-Paraffin: EGFR Antibody (GFR/1667) [NBP2-53346] - Formalin-fixed, paraffin-embedded human Placenta stained with EGFR Antibody (GFR/1667).](http://images.novusbio.com/fullsize/EGFR-Antibody-GFR-1667-Immunohistochemistry-Paraffin-NBP2-53346-img0005.jpg)
![Immunohistochemistry-Paraffin: EGFR Antibody (GFR/1667) [NBP2-53346] - Formalin-fixed, paraffin-embedded human Lung SCC stained with EGFR Monoclonal Antibody (GFR/1667).](http://images.novusbio.com/fullsize/EGFR-Antibody-GFR-1667-Immunohistochemistry-Paraffin-NBP2-53346-img0001.jpg)
![Immunohistochemistry-Paraffin: EGFR Antibody (GFR/1667) [NBP2-53346] - Formalin-fixed, paraffin-embedded human Bladder stained with EGFR Antibody (GFR/1667).](http://images.novusbio.com/fullsize/EGFR-Antibody-GFR-1667-Immunohistochemistry-Paraffin-NBP2-53346-img0004.jpg)
![Immunohistochemistry-Paraffin: p53 Antibody (BP53-12 + DO-7) [NBP2-34309] - Formalin-fixed, paraffin-embedded human cervical carcinoma stained with P53 Monoclonal antibody (BP53-12 +DO-7)](http://images.novusbio.com/fullsize/p53-Antibody-BP53-12-+-DO-7-Immunohistochemistry-Paraffin-NBP2-34309-img0002.jpg "Immunohistochemistry-Paraffin: p53 Antibody (BP53-12 + DO-7) [NBP2-34309] - Formalin-fixed, paraffin-embedded human cervical carcinoma stained with P53 Monoclonal antibody (BP53-12 +DO-7)")
![Western Blot: EML4 Antibody [NBP1-05973] - Detection of Human EML4 by Western Blot. Samples: Whole cell lysate (50, 15 ug) from HeLa cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-EML4 antibody NBP1-05973 used for WB at 0.04 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/EML4-Antibody-Western-Blot-NBP1-05973-img0004.jpg "Western Blot: EML4 Antibody [NBP1-05973] - Detection of Human EML4 by Western Blot. Samples: Whole cell lysate (50, 15 ug) from HeLa cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-EML4 antibody NBP1-05973 used for WB at 0.04 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.")
![Immunohistochemistry-Paraffin: EML4 Antibody [NBP1-05973] - FFPE section of human ovarian carcinoma. Antibody: Affinity purified rabbit anti-EML4 used at a dilution of1:1000 (0.2ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/EML4-Antibody-Immunohistochemistry-Paraffin-NBP1-05973-img0005.jpg)
![<b>Independent Antibodies Validation. </b>Immunoprecipitation: EML4 Antibody [NBP1-05973] - Detection of human EML4 by western blot of immunoprecipitates. Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-EML4 antibody NBP1-05973 (lot NBP1-05973-2) used for IP at 6 ug per reaction. EML4 was also immunoprecipitated by a previous lot of this antibody (lot NBP1-05973-1) and rabbit anti-EML4 antibody NBP1-05974. For blotting immunoprecipitated EML4, NBP1-05973 was used at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.](http://images.novusbio.com/fullsize/EML4-Antibody-Immunoprecipitation-NBP1-05973-img0006.jpg)
![Immunohistochemistry: c-jun [p Ser 63] Antibody (SR1842) [NBP3-21583] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NBP3-21583.](http://images.novusbio.com/fullsize/nbp3-21583_rabbit-c-jun-p-ser-63-mab-sr1842-57202316112182.jpg "Immunohistochemistry: c-jun [p Ser 63] Antibody (SR1842) [NBP3-21583] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NBP3-21583.")
![Western Blot: c-jun [p Ser 63] Antibody (SR1842) [NBP3-21583] - Western blot analysis using NBP3-21583 in NIH/3T3 cell lysate treated with Anisomycin.](http://images.novusbio.com/fullsize/nbp3-21583_rabbit-c-jun-p-ser-63-mab-sr1842-5720231523499.jpg)
![Immunocytochemistry/Immunofluorescence: c-jun [p Ser 63] Antibody (SR1842) [NBP3-21583] - Immunofluorescent analysis of HeLa cells treated with anisomycin, using NBP3-21583.](http://images.novusbio.com/fullsize/nbp3-21583_rabbit-c-jun-p-ser-63-mab-sr1842-6720231051269.jpg)
![Western Blot: MKK6/MEK6 [p Ser207] Antibody [NB100-82050] - Analysis of extracts from HL60 cells untreated or treated with PMA using MKK6(Phospho-Ser207) antibody](http://images.novusbio.com/fullsize/MKK6-MEK6-[p-Ser207]-Antibody-Western-Blot-NB100-82050-img0003.jpg "<b>Biological Strategies Validation. </b>Western Blot: MKK6/MEK6 [p Ser207] Antibody [NB100-82050] - Analysis of extracts from HL60 cells untreated or treated with PMA using MKK6(Phospho-Ser207) antibody")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: MKK6/MEK6 [p Ser207] Antibody [NB100-82050] - Immunohistochemical analysis of paraffin- embedded human breast carcinoma tissue, using NB100-82050(left) or the same antibody preincubated with blocking peptide (right).](http://images.novusbio.com/fullsize/nb100-82050_rabbit-polyclonal-mkk6-mek6-p-ser207-antibody-103202523464556.jpg)
![Immunocytochemistry/Immunofluorescence: MKK6/MEK6 [p Ser207] Antibody [NB100-82050] - Staining of methanol-fixed Hela cells showing cytoplasmic staining using NB100-82050](http://images.novusbio.com/fullsize/nb100-82050_rabbit-polyclonal-mkk6-mek6-p-ser207-antibody-1132025155591.jpg)
![Western Blot: MKK6/MEK6 Antibody (2F2) [H00005608-M02] - MAP2K6 monoclonal antibody (M02), clone 2F2 Analysis of MAP2K6 expression in COLO 320 HSR.](http://images.novusbio.com/fullsize/MKK6-MEK6-Antibody-2F2-Western-Blot-H00005608-M02-img0009.jpg "Western Blot: MKK6/MEK6 Antibody (2F2) [H00005608-M02] - MAP2K6 monoclonal antibody (M02), clone 2F2 Analysis of MAP2K6 expression in COLO 320 HSR.")
![Immunocytochemistry/Immunofluorescence: MKK6/MEK6 Antibody (2F2) [H00005608-M02] - Analysis of monoclonal antibody to MAP2K6 on HeLa cell. Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/MKK6-MEK6-Antibody-2F2-Immunocytochemistry-Immunofluorescence-H00005608-M02-img0007.jpg)
![Proximity Ligation Assay: MKK6/MEK6 Antibody (2F2) [H00005608-M02] - Analysis of protein-protein interactions between MAP2K3 and MAP2K6. HeLa cells were stained with anti-MAP2K3 rabbit purified polyclonal 1:1200 and anti-MAP2K6 mouse monoclonal antibody 1:50. Each red dot represents the detection of protein-protein interaction complex, and nuclei were counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/MKK6-MEK6-Antibody-2F2-Proximity-Ligation-Assay-H00005608-M02-img0005.jpg)
![Sandwich ELISA: MKK6/MEK6 Antibody (2F2) [H00005608-M02] - Detection limit for recombinant GST tagged MAP2K6 is approximately 0.3ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/MKK6-MEK6-Antibody-2F2-Sandwich-ELISA-H00005608-M02-img0008.jpg)
![Immunohistochemistry-Paraffin: WT1 Antibody (WT1/3477R) [NBP3-07221] - FFPE human kidney. PBS instead of primary antibody. Secondary antibody only negative control. Hematoxylin counterstain.](http://images.novusbio.com/fullsize/WT1-Antibody-WT1-3477R-Immunohistochemistry-Paraffin-NBP3-07221-img0003.jpg "Immunohistochemistry-Paraffin: WT1 Antibody (WT1/3477R) [NBP3-07221] - FFPE human kidney. PBS instead of primary antibody. Secondary antibody only negative control. Hematoxylin counterstain.")
![Immunohistochemistry-Paraffin: WT1 Antibody (WT1/3477R) [NBP3-07221] - FFPE human kidney sections. Wilm's Tumor 1 labeled using WT1 (WT1/3477R) (1?g/ml). HIER: Tris/EDTA (pH9.0). HRP-Polymer. Hematoxylin counterstain.](http://images.novusbio.com/fullsize/WT1-Antibody-WT1-3477R-Immunohistochemistry-Paraffin-NBP3-07221-img0001.jpg)
![Immunohistochemistry-Paraffin: WT1 Antibody (WT1/3477R) [NBP3-07221] - FFPE human kidney. Secondary antibody only negative control. Hematoxylin counterstain.](http://images.novusbio.com/fullsize/WT1-Antibody-WT1-3477R-Immunohistochemistry-Paraffin-NBP3-07221-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: Cdk9 Antibody [NBP1-86808] - Staining of human cell line U-2 OS shows localization to nucleoplasm & cytoplasmic bodies.](http://images.novusbio.com/fullsize/Cdk9-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-86808-img0006.jpg "Immunocytochemistry/Immunofluorescence: Cdk9 Antibody [NBP1-86808] - Staining of human cell line U-2 OS shows localization to nucleoplasm & cytoplasmic bodies.")
![Immunohistochemistry-Paraffin: Cdk9 Antibody [NBP1-86808] - Staining of human oral mucosa shows strong nuclear positivity in squamous epithelial cells.](http://images.novusbio.com/fullsize/Cdk9-Antibody-Immunohistochemistry-Paraffin-NBP1-86808-img0007.jpg)
![Western Blot: CDC25B Antibody [NBP2-32626] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG sp](http://images.novusbio.com/fullsize/CDC25B-Antibody-Western-Blot-NBP2-32626-img0007.jpg "Western Blot: CDC25B Antibody [NBP2-32626] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG sp")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CDC25B Antibody [NBP2-32626] - Staining in human lymph node and pancreas tissues using anti-CDC25B antibody. Corresponding CDC25B RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CDC25B-Antibody-Immunohistochemistry-Paraffin-NBP2-32626-img0012.jpg)
![Immunohistochemistry-Paraffin: CDC25B Antibody [NBP2-32626] - Staining of human lymph node shows high expression.](http://images.novusbio.com/fullsize/CDC25B-Antibody-Immunohistochemistry-Paraffin-NBP2-32626-img0010.jpg)
![Immunohistochemistry-Paraffin: CDC25B Antibody [NBP2-32626] - Staining of human pancreas shows low expression as expected.](http://images.novusbio.com/fullsize/CDC25B-Antibody-Immunohistochemistry-Paraffin-NBP2-32626-img0011.jpg)